NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT03419494 2018-02-05Comparison of Liposomal Doxorubicin and Daunorubicin-containing VDCLD Regimen in the Treatment of Adult ALL PatientsCSPC ZhongQi Pharmaceutical Technology Co., Ltd.Unknown40 enrolled